Efficacy and tolerability of valsartan compared with lisinopril in patients with hypertension and renal insufficiency
N Perico, D Spormann, E Peruzzi, F Bodin… - Clinical drug …, 1997 - Springer
This study compared the efficacy and tolerability of valsartan with an angiotensin converting
enzyme inhibitor, lisinopril, in hypertensive patients with renal insufficiency. A total of 188 …
enzyme inhibitor, lisinopril, in hypertensive patients with renal insufficiency. A total of 188 …
Low-dose combination therapy with perindopril and indapamide compared with irbesartan
T Morgan, A Anderson - Clinical drug investigation, 2002 - Springer
Introduction: A study was undertaken in patients with essential hypertension to compare, by
ambulatory blood pressure monitoring, the response to a fixed low dose of perindopril …
ambulatory blood pressure monitoring, the response to a fixed low dose of perindopril …
Efficacy and safety of valsartan compared with enalapril at different altitudes
R Botero, H Matiz, E Marıa, H Orejarena… - International journal of …, 2000 - Elsevier
Objective: To compare the safety, tolerability, and antihypertensive efficacy of valsartan with
enalapril at different altitudes. Method: A total of 142 adult Colombian outpatients with mild …
enalapril at different altitudes. Method: A total of 142 adult Colombian outpatients with mild …
氯沙坦合用苯那普利对慢性肾炎肾保护作用的临床研究
凌汉新， 蔡倩彤， 孙升云 - 中国热带医学, 2009 - cqvip.com
目的观察氯沙坦合用苯那普利对慢性肾脏病保护作用. 方法治疗组50 例慢性肾炎患者应用氯沙
坦合用苯那普利和对照组30 例慢性肾炎患者应用依那普利前及应用8 周后血钾, 钠, 氯, 24h …
坦合用苯那普利和对照组30 例慢性肾炎患者应用依那普利前及应用8 周后血钾, 钠, 氯, 24h …
Effects of valsartan and enalapril on regression of left ventricular hypertrophy in patients with mild to moderate hypertension: a randomized, double-blind study
S Nalbantgil, H Yilmaz, C Gurun, F Özerkan… - Current therapeutic …, 2000 - Elsevier
OBJECTIVE: This study was undertaken to compare the effects of valsartan with those of
enalapril on regression of left ventricular hypertrophy in patients with mild to moderate …
enalapril on regression of left ventricular hypertrophy in patients with mild to moderate …
Clinical differences among angiotensin II receptor antagonists
G Mancia - Blood Pressure, 2001 - Taylor & Francis
The six major classes of antihypertensive agents prescribed worldwide are similar in efficacy
but dissimilar in tolerability. Recently, the World Health Organization-International Society of …
but dissimilar in tolerability. Recently, the World Health Organization-International Society of …
缬沙坦与氨氯地平治疗轻, 中度原发性高血压的疗效比较
杨昆， 郭庆畲 - 中国心血管杂志, 2001 - cqvip.com
目的比较缬沙坦(Valsartan) 与氨氯地平(Amlodipine) 的降压疗效. 方法86 例患轻,
中度原发性高血压的门诊或住院患者被随机分为80mg 缬沙坦或5mg 氨氯地平组, 共服药8 周 …
中度原发性高血压的门诊或住院患者被随机分为80mg 缬沙坦或5mg 氨氯地平组, 共服药8 周 …
[HTML][HTML] Radioiodination and biological evaluation of valsartan as a tracer for cardiovascular disorder detection
AM Amin, A Abd El-bary, A Abd El-Mohty, SM Saad… - 2013 - scirp.org
A procedure for radioiodination of valsartan with iodine-125 is carried out via an electrophilic
substitution of hydrogen atom with the iodonium cation I+. All reaction parameters were …
substitution of hydrogen atom with the iodonium cation I+. All reaction parameters were …
Clinical advantage of valsartan
GT McInnes - Cardiology, 1999 - karger.com
Valsartan is a specific angiotensin II receptor antagonist with high selectivity for the AT 1
receptor subtype. After oral administration of single or repeated once-daily doses, valsartan …
receptor subtype. After oral administration of single or repeated once-daily doses, valsartan …
缬沙坦与赖诺普利治疗原发性高血压患者在耐受性, 安全性和疗效上的比较
谭慧琼， 朱俊， 于丽天， 章晏， 郭素芳， 黄永麟， 关德明 - 中国循环杂志, 2000 - cqvip.com
目的: 评价缬沙坦(valsartan) 治疗原发性高血压患者的耐受性, 安全性和疗效. 方法: 146 例轻,
中度原发性高血压患者采用同双盲的研究方法分为缬沙坦组(n= 75) 和赖诺普利(lisinopril) …
中度原发性高血压患者采用同双盲的研究方法分为缬沙坦组(n= 75) 和赖诺普利(lisinopril) …